Found: 35
Select item for more details and to access through your institution.
RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal Cancer.
- Published in:
- Current Oncology Reports, 2016, v. 18, n. 3, p. 1, doi. 10.1007/s11912-016-0504-2
- By:
- Publication type:
- Article
Chemotherapy in Resected Neuroendocrine Carcinomas of the Digestive Tract: A National Study from the French Group of Endocrine Tumours.
- Published in:
- Neuroendocrinology, 2020, v. 110, n. 5, p. 404, doi. 10.1159/000502825
- By:
- Publication type:
- Article
Deficient mismatch repair/microsatellite unstable colorectal cancer: therapeutic advances and questions.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359231170473
- By:
- Publication type:
- Article
La thérapie personnalisée en oncologie digestive : quoi de neuf ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2023, v. 30, n. 5, p. 524, doi. 10.1684/hpg.2023.2575
- By:
- Publication type:
- Article
Cancers colorectaux avec instabilité microsatellite : les avancées thérapeutiques et les interrogations.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2023, v. 30, n. 3, p. 315, doi. 10.1684/hpg.2023.2539
- By:
- Publication type:
- Article
Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211020547
- By:
- Publication type:
- Article
Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211020547
- By:
- Publication type:
- Article
Long-Term Survival in Locally Advanced KRAS Wild-Type Pancreatic Adenocarcinoma.
- Published in:
- Case Reports in Gastrointestinal Medicine, 2019, p. 1, doi. 10.1155/2019/8598635
- By:
- Publication type:
- Article
Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 406, doi. 10.3390/cancers14020406
- By:
- Publication type:
- Article
Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1149, doi. 10.3390/cancers13051149
- By:
- Publication type:
- Article
Molecular Targets for the Treatment of Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2350, doi. 10.3390/cancers12092350
- By:
- Publication type:
- Article
Immunotherapy for Early Stage Colorectal Cancer: A Glance into the Future.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1990, doi. 10.3390/cancers12071990
- By:
- Publication type:
- Article
BRAF Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 998, doi. 10.3390/cancers11070998
- By:
- Publication type:
- Article
Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 11, p. 2260, doi. 10.1002/1878-0261.13173
- By:
- Publication type:
- Article
Severe necrotizing myositis associated with long term anti-neoplastic efficacy following nivolumab plus ipilimumab combination therapy.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 2, p. 601, doi. 10.1007/s10067-018-4373-y
- By:
- Publication type:
- Article
Prognostic value of Lynch syndrome, BRAF<sup>V600E</sup>, and RAS mutational status in dMMR/MSI‐H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 15, p. 15841, doi. 10.1002/cam4.6223
- By:
- Publication type:
- Article
Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial
- Published in:
- Cancer Medicine, 2019, v. 8, n. 11, p. 5079, doi. 10.1002/cam4.2311
- By:
- Publication type:
- Article
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 7, p. 1376, doi. 10.1002/ijc.34636
- By:
- Publication type:
- Article
BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Consequences of the Hsp110DE9 mutation in tumorigenesis and the 5-fluorouracil-based chemotherapy response in Msh2-deficient mice.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 6, p. 1, doi. 10.1007/s00018-022-04293-3
- By:
- Publication type:
- Article
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study.
- Published in:
- World Journal of Surgical Oncology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12957-022-02594-2
- By:
- Publication type:
- Article
Impact of the IDEA Collaboration Study Results on Clinical Practice in France for Patients With Stage III Colon Cancer: A National GERCOR - PRODIGE Survey.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 442, doi. 10.1038/s41416-023-02524-3
- By:
- Publication type:
- Article
Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond.
- Published in:
- 2020
- By:
- Publication type:
- journal article
L'immunothérapie pour les cancers colorectaux, c'est pour quand ?
- Published in:
- 2019
- By:
- Publication type:
- Editorial
BRAF<sup>V600E</sup>/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. 771, doi. 10.1093/oncolo/oyad082
- By:
- Publication type:
- Article
Characteristics of BRAF<sup>V600E</sup> Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1331, doi. 10.1634/theoncologist.2018-0914
- By:
- Publication type:
- Article
Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
BRAF V600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial Origin.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trials.
- Published in:
- Clinical Trials, 2021, v. 18, n. 1, p. 51, doi. 10.1177/1740774520959313
- By:
- Publication type:
- Article